Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
Search results for: methotrexate
Does Gastric Bypass Result in Reduced Absorption of Methotrexate?
Data suggest changes in physiology of the gut post-bariatric surgery may result in medication malabsorption of immunosuppressive drugs
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Methotrexate & Adverse Respiratory Events
A secondary review
Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium
By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine
Research into Methotrexate Could Lead to Improved Treatments for Rheumatoid Arthritis
With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints
A&R Abstracts: Methotrexate
For further reading
The Roles of the Interdisciplinary Rheumatology Team in Patient Care Highlighted
To work together effectively, clinicians and rheumatology professionals need to understand the roles of every member of the interdisciplinary team. To enhance this understanding, the ARP Interprofessional Practice & Management Committee has undertaken a project to describe the modern roles of members of the interdisciplinary team in a series of fact sheets. The first three…
Make Way for the Interprofessional Rheumatology Team!
Editor’s note: Originally published on Oct. 12, 2023. Updated Feb. 28, 2024, to add fact sheets. According to the Agency for Healthcare Research and Quality (AHRQ), a leading cause of medical errors and poor care is a lack of communication between healthcare providers.1 As healthcare has evolved, the importance of holistic care has become more…
Duke University Names Dr. Megan Clowse to Lead Rheumatology Division
In October 2023, Megan E.B. Clowse, MD, MPH, a renowned expert in the field of rheumatology and immunology, was named the new chief of the Division of Rheumatology and Immunology at Duke University School of Medicine, Durham, N.C. Dr. Clowse, who serves as an associate professor of medicine in Duke’s Division of Rheumatology and Immunology…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 100
- Next Page »